Top Markets
#1 Black Phoenix Black Phoenix +736.87%
#2 Beam Beam +34.66%
#3 Tutorial Tutorial +22.08%
#4 SAFEcoin SAFEcoin +19.82%
#5 THORChain THORChain +18.69%
#6 Bless Bless +17.59%
#7 EfficientFrontier EfficientFrontier +14.98%
#8 THORChain Yield THORChain Yield +14.02%
#9 Versatize Coin Versatize Coin +12.50%
#10 TENDIES TENDIES +11.94%
Coin of the day
Black Phoenix Black Phoenix
설정
언어
한국어
통화
USD
테마
RayzeBio, Inc. Common Stock RayzeBio, Inc. Common Stock

RayzeBio, Inc. Common Stock

RYZB
주식 순위 #5675
RayzeBio, Inc. is dedicated to creating radiopharmaceutical therapies (RPTs)... RayzeBio, Inc. is dedicated to creating radiopharmaceutical therapies (RPTs) for oncology applications. Its primary therapeutic candidate, RYZ101, is currently advancing through Phase 3 clinical trials for the management of gastroenteropancreatic neuroendocrine tumors (GEP-NETs). The company's innovative pipeline also features RYZ801, a distinct peptide engineered to deliver Actinium-225 (Ac225) by targeting GPC3, intended for treating hepatocellular carcinoma (HCC). Additionally, RayzeBio is developing RYZ811, a companion diagnostic imaging agent comprising a peptide binder, a chelator, and Gallium-68 (Ga68). Another active development program involves a novel proprietary small molecule designed to target CA9, delivering Ac225 for potential use against clear cell renal cell carcinoma (ccRCC). The firm was established in 2020 and is headquartered in San Diego, California.
주가
$62.49
마지막 동기화: 2024-03-06
시가총액
$2.52B
변동 (1일)
0.00%
변동 (1년)
0.00%
국가
US
거래 RayzeBio, Inc. Common Stock (RYZB)

카테고리

Healthcare
RayzeBio, Inc. Common Stock (RYZB)의 주가 이력
최고 종가: $62.49 (2024-03-01 기준)

최저 종가: $20.99 (2023-09-01 기준)
RayzeBio, Inc. Common Stock의 주가 이력 (2023 ~ 2026)
연간 주가 성과
연도 성과
2024 87.31%
2023 0.00%
유사 기업 또는 경쟁사의 주가
회사 주가 변동률 1년% 국가
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $549.38 41.20%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.05K 47.75%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $148.35 491.02%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $122.63 -12.65%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $762.13 6.76%
CH